Logo image of HRZN

HORIZON TECHNOLOGY FINANCE C (HRZN) Stock Fundamental Analysis

USA - NASDAQ:HRZN - US44045A1025 - Common Stock

6.14 USD
-0.08 (-1.29%)
Last: 9/26/2025, 8:00:02 PM
6.1947 USD
+0.05 (+0.89%)
After Hours: 9/26/2025, 8:00:02 PM
Fundamental Rating

2

Overall HRZN gets a fundamental rating of 2 out of 10. We evaluated HRZN against 237 industry peers in the Capital Markets industry. HRZN may be in some trouble as it scores bad on both profitability and health. HRZN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HRZN had positive earnings in the past year.
In the past year HRZN has reported a negative cash flow from operations.
In multiple years HRZN reported negative net income over the last 5 years.
In the past 5 years HRZN reported 4 times negative operating cash flow.
HRZN Yearly Net Income VS EBIT VS OCF VS FCFHRZN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M

1.2 Ratios

HRZN's Return On Assets of -6.52% is on the low side compared to the rest of the industry. HRZN is outperformed by 83.12% of its industry peers.
With a Return On Equity value of -16.69%, HRZN is not doing good in the industry: 79.32% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.52%
ROE -16.69%
ROIC N/A
ROA(3y)-0.02%
ROA(5y)1.38%
ROE(3y)-0.11%
ROE(5y)2.8%
ROIC(3y)N/A
ROIC(5y)N/A
HRZN Yearly ROA, ROE, ROICHRZN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

HRZN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HRZN Yearly Profit, Operating, Gross MarginsHRZN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, HRZN has more shares outstanding
Compared to 5 years ago, HRZN has more shares outstanding
Compared to 1 year ago, HRZN has an improved debt to assets ratio.
HRZN Yearly Shares OutstandingHRZN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
HRZN Yearly Total Debt VS Total AssetsHRZN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

HRZN has an Altman-Z score of -0.40. This is a bad value and indicates that HRZN is not financially healthy and even has some risk of bankruptcy.
HRZN has a worse Altman-Z score (-0.40) than 77.22% of its industry peers.
A Debt/Equity ratio of 1.08 is on the high side and indicates that HRZN has dependencies on debt financing.
With a Debt to Equity ratio value of 1.08, HRZN perfoms like the industry average, outperforming 45.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF N/A
Altman-Z -0.4
ROIC/WACCN/A
WACCN/A
HRZN Yearly LT Debt VS Equity VS FCFHRZN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 0.67 indicates that HRZN may have some problems paying its short term obligations.
With a Current ratio value of 0.67, HRZN is not doing good in the industry: 67.09% of the companies in the same industry are doing better.
HRZN has a Quick Ratio of 0.67. This is a bad value and indicates that HRZN is not financially healthy enough and could expect problems in meeting its short term obligations.
HRZN has a worse Quick ratio (0.67) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.67
HRZN Yearly Current Assets VS Current LiabilitesHRZN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for HRZN have decreased strongly by -33.72% in the last year.
HRZN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.38% yearly.
Looking at the last year, HRZN shows a very negative growth in Revenue. The Revenue has decreased by -78.34% in the last year.
Measured over the past years, HRZN shows a small growth in Revenue. The Revenue has been growing by 1.98% on average per year.
EPS 1Y (TTM)-33.72%
EPS 3Y-1.7%
EPS 5Y-2.38%
EPS Q2Q%-22.22%
Revenue 1Y (TTM)-78.34%
Revenue growth 3Y-8.13%
Revenue growth 5Y1.98%
Sales Q2Q%-4.51%

3.2 Future

Based on estimates for the next years, HRZN will show a decrease in Earnings Per Share. The EPS will decrease by -9.70% on average per year.
HRZN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.00% yearly.
EPS Next Y-15.95%
EPS Next 2Y-11.92%
EPS Next 3Y-9.7%
EPS Next 5YN/A
Revenue Next Year-4.14%
Revenue Next 2Y2.5%
Revenue Next 3Y11%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HRZN Yearly Revenue VS EstimatesHRZN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M
HRZN Yearly EPS VS EstimatesHRZN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

HRZN is valuated cheaply with a Price/Earnings ratio of 5.39.
Based on the Price/Earnings ratio, HRZN is valued cheaply inside the industry as 93.67% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.54. HRZN is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 5.95, the valuation of HRZN can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HRZN indicates a rather cheap valuation: HRZN is cheaper than 94.09% of the companies listed in the same industry.
HRZN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.05.
Industry RankSector Rank
PE 5.39
Fwd PE 5.95
HRZN Price Earnings VS Forward Price EarningsHRZN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HRZN Per share dataHRZN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A cheap valuation may be justified as HRZN's earnings are expected to decrease with -9.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.92%
EPS Next 3Y-9.7%

More info and screens

5

5. Dividend

5.1 Amount

HRZN has a Yearly Dividend Yield of 11.74%, which is a nice return.
Compared to an average industry Dividend Yield of 8.30, HRZN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, HRZN pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.74%

5.2 History

The dividend of HRZN has a limited annual growth rate of 1.93%.
HRZN has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)1.93%
Div Incr Years0
Div Non Decr Years0
HRZN Yearly Dividends per shareHRZN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

HRZN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-103.55%
EPS Next 2Y-11.92%
EPS Next 3Y-9.7%
HRZN Yearly Income VS Free CF VS DividendHRZN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M

More info and screens

HORIZON TECHNOLOGY FINANCE C

NASDAQ:HRZN (9/26/2025, 8:00:02 PM)

After market: 6.1947 +0.05 (+0.89%)

6.14

-0.08 (-1.29%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners6.54%
Inst Owner Change-17.2%
Ins Owners1.24%
Ins Owner Change0%
Market Cap261.26M
Analysts51.67
Price Target6.89 (12.21%)
Short Float %3.76%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield 11.74%
Yearly Dividend1.27
Dividend Growth(5Y)1.93%
DP-103.55%
Div Incr Years0
Div Non Decr Years0
Ex-Date11-17 2025-11-17 (0.11)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.02%
Min EPS beat(2)-18.73%
Max EPS beat(2)-1.3%
EPS beat(4)0
Avg EPS beat(4)-11.83%
Min EPS beat(4)-18.73%
Max EPS beat(4)-1.3%
EPS beat(8)1
Avg EPS beat(8)-3.33%
EPS beat(12)5
Avg EPS beat(12)3.04%
EPS beat(16)8
Avg EPS beat(16)3.05%
Revenue beat(2)0
Avg Revenue beat(2)-5.75%
Min Revenue beat(2)-9.48%
Max Revenue beat(2)-2.03%
Revenue beat(4)0
Avg Revenue beat(4)-6.79%
Min Revenue beat(4)-10.13%
Max Revenue beat(4)-2.03%
Revenue beat(8)1
Avg Revenue beat(8)-3.8%
Revenue beat(12)3
Avg Revenue beat(12)-4.95%
Revenue beat(16)5
Avg Revenue beat(16)-3.41%
PT rev (1m)-2.41%
PT rev (3m)-7.35%
EPS NQ rev (1m)0.67%
EPS NQ rev (3m)-2.88%
EPS NY rev (1m)0.4%
EPS NY rev (3m)-2.01%
Revenue NQ rev (1m)-1.88%
Revenue NQ rev (3m)-3.22%
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)-1.52%
Valuation
Industry RankSector Rank
PE 5.39
Fwd PE 5.95
P/S 42.68
P/FCF N/A
P/OCF N/A
P/B 0.92
P/tB 0.92
EV/EBITDA N/A
EPS(TTM)1.14
EY18.57%
EPS(NY)1.03
Fwd EY16.81%
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS0.14
BVpS6.67
TBVpS6.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.52%
ROE -16.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-0.02%
ROA(5y)1.38%
ROE(3y)-0.11%
ROE(5y)2.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.67
Altman-Z -0.4
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.72%
EPS 3Y-1.7%
EPS 5Y-2.38%
EPS Q2Q%-22.22%
EPS Next Y-15.95%
EPS Next 2Y-11.92%
EPS Next 3Y-9.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-78.34%
Revenue growth 3Y-8.13%
Revenue growth 5Y1.98%
Sales Q2Q%-4.51%
Revenue Next Year-4.14%
Revenue Next 2Y2.5%
Revenue Next 3Y11%
Revenue Next 5YN/A
EBIT growth 1Y-113.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.99%
OCF growth 3YN/A
OCF growth 5YN/A